Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Dig Liver Dis ; 34(11): 775-80, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12546512

ABSTRACT

BACKGROUND: Autonomic function in inflammatory bowel disease has not yet been studied by means of analysis of 24-hour heart rate variability. AIM: To measure heart rate variability in inflammatory bowel disease patients in remission. PATIENTS AND METHODS: Study population comprised 27 patients with inflammatory bowel disease in remission and 28 healthy, sex- and age-matched controls. Two frequency ranges were analysed: low frequency (0.06-0.15 Hz) and high frequency (0.15-0.40 Hz). RESULTS: Mean values of low frequency and low frequency/high frequency ratio were lower in patients than in controls (p < 0.001). High frequency in patients tended to be higher than in controls (p = 0.09). The only factor that had a marginal effect on heart rate variability indexes was age. In high frequency, there was a significant time effect (p = 0.001) for both groups. There was also a significant time effect in low frequency/high frequency ratio in both groups (p < 0.001). During daytime, the mean values in low frequency/high frequency ratio were lower in patients than in controls (p < 0.001). CONCLUSIONS: There is a shift in the autonomic balance in patients with inflammatory bowel disease in remission towards a condition of relative parasympathetic predominance, which, in the first place, reflects a sympathetic pullback. This imbalance has a circadian rhythm and it is more pronounced during the day.


Subject(s)
Autonomic Nervous System Diseases/complications , Autonomic Nervous System Diseases/diagnosis , Chronobiology Disorders/complications , Inflammatory Bowel Diseases/complications , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Chronobiology Disorders/diagnosis , Electrocardiography, Ambulatory/methods , Female , Heart Rate/physiology , Humans , Inflammatory Bowel Diseases/drug therapy , Male , Mesalamine/therapeutic use , Middle Aged , Remission Induction
SELECTION OF CITATIONS
SEARCH DETAIL
...